收藏切换
Mini health technology assessment of four antiangiogenic agents for advanced NSCLC
收藏切换
Bing-nan REN, Chao-jun XUE, Xiao LI, Yue ZHAO, Zhan-jun DONG
Chinese Journal of New Drugs | 2021, 30(21) : 2009 - 2016
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(21): 2009-2016
Mini health technology assessment of four antiangiogenic agents for advanced NSCLC
Full
Bing-nan REN, Chao-jun XUE, Xiao LI, Yue ZHAO, Zhan-jun DONG
Affiliations
  • Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, China
Published: 2021-11-15
Outline
收藏切换
Objective:

To provide a basis for drug selection, as well as safe and rational use of drugs, Mini health technology assessment was used for 4 antiangiogenic agents for the treatment of advanced NSCLC (bevacizumab, ramucirumab, anlotinib, recombinant human endostatin).

Methods:

Mini health technology assessment was conducted for the 4 mentioned antiangiogenic agents based on ten aspects, such as pharmaceutical characteristics, effectiveness, safety, economy, medical insurance, national essential drug, storage conditions, expiration date, global use and corporate credibility.

Results:

Based on the above evaluation criteria, the scores of the four antiangiogenic agents ranged 61~72. The difference in scores was mainly in terms of effectiveness, safety, economy, and storage conditions. Arotinib scored high in the treatment of small cell lung cancer, and was recommended in the drug selection list of medical institutions.

Conclusion:

Mini health technology assessment is a multi-dimensional evaluation of drugs, providing basis for hospital drug selection, safe and rational use. It is of relatively high promotion value.

non-small cell lung cancer (NSCLC)  /  bevacizumab  /  ramucirumab  /  anlotinib  /  recombinant human endostatin  /  Mini health technology assessment
任炳楠, 薛朝军, 李宵, 赵越, 董占军. 4种治疗晚期非小细胞肺癌的抗血管生成药物Mini卫生技术评估. 中国新药杂志, 2021 , 30 (21) : 2009 -2016 .
Bing-nan REN, Chao-jun XUE, Xiao LI, Yue ZHAO, Zhan-jun DONG. Mini health technology assessment of four antiangiogenic agents for advanced NSCLC[J]. Chinese Journal of New Drugs, 2021 , 30 (21) : 2009 -2016 .
Year 2021 volume 30 Issue 21
23
2
Cite this Article
BibTeX
Article Info
  • Online Date:2026-10-30
  • Published:2021-11-15
Article Data
Affiliations
History
  • Accepted:2021-07-16
Affiliations
    Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT